Skip to main content

Lemonade rival Hippo picks up $100m in latest funding round

Hippo

Lemonade competitor Hippo has raised $100m (£78.9m) in a Series D funding round, led by Bond Capital.

US-based home insurance insurtech Hippo, which launched in 2017, has raised $209m in total.

It intends to use the capital raise to move into further US states, with a target of being available to 80%

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Register

Want to know what’s included in our free registration? Click here

Already have an account? Sign in here

Show password
Hide password

Are motor premiums nearing equilibrium?

To kick off Motor Week, Stephen Kennedy, director at Defaqto, reveals after a sharp correction, falling motor premiums are beginning to level off, suggesting a more stable yet uneven competitive landscape ahead.

Diary of an Insurer: Ticker’s Rachel Green

Rachel Green, fraud manager at connected motor insurer Ticker, catches the "bad guys", digs deep into the data, judges developments shaping the industry, trains the in-house AI fraud detection system, and ends the week with a trip to a tumble class.

Allianz drops LV rebrand plans

Allianz UK and LV have announced a new multi-year partnership to continue distribution of insurance under the LV= brand, despite previously planning to phase the brand name out in 2026.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here